ACM
GSK icon

Ativo Capital Management’s GSK GSK Stock Holding History

Ativo Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23,615
Closed -$965K – 52
2024
Q3 		$965K Sell
23,615
-149
-0.6% -$6.09K 0.84% 49
2024
Q2 		$915K Sell
23,764
-200
-0.8% -$8.41K 0.95% 45
2024
Q1 		$1.03M Buy
23,964
+98
+0.4% +$4.04K 1.03% 44
2023
Q4 		$884K Sell
23,866
-197
-0.8% -$7.07K 0.94% 46
2023
Q3 		$872K Sell
24,063
-202
-0.8% -$7.17K 0.99% 44
2023
Q2 		$865K Sell
24,265
-1,117
-4% -$40.1K 0.91% 45
2023
Q1 		$903K Buy
25,382
+2,801
+12% +$98K 1.11% 41
2022
Q4 		$793K Sell
22,581
-1,200
-5% -$40K 1% 49
2022
Q3 		$700K Buy
23,781
+11
+0% +$417 1.1% 46
2022
Q2 		$1.29M Sell
23,770
-4,400
-16% -$243K 0.87% 36
2022
Q1 		$1.53M Buy
28,170
+74
+0.3% +$4.02K 0.79% 51
2021
Q4 		$1.55M Sell
28,096
-482
-2% -$25.1K 0.69% 72
2021
Q3 		$1.36M Buy
28,578
+2,946
+11% +$148K 0.64% 71
2021
Q2 		$1.28M Sell
25,632
-1,589
-6% -$76.3K 0.54% 89
2021
Q1 		$1.21M Buy
27,221
+1
+0% +$45 0.52% 81
2020
Q4 		$1.25M Buy
27,220
+3,686
+16% +$169K 0.54% 70
2020
Q3 		$1.11M Buy
23,534
+16,400
+230% +$822K 0.53% 72
2020
Q2 		$364K Buy
+7,134
New +$366K 0.2% 98

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ativo Capital Management's GSK Position: Q4 2024 in Review

Ativo Capital Management sold out of GSK (GSK) in Q4 2024, closing a stake of 23,615 shares — an estimated $965K sold.

Ativo Capital Management first reported a position in GSK in Q2 2020 and held it in 18 quarters. The position peaked at $1.55M in Q4 2021. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Ativo Capital Management reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Ativo Capital Management sold 23,615 GSK shares in Q4 2024, an estimated $965K.
  • Ativo Capital Management first reported a position in GSK in Q2 2020 and held it in 18 quarters.
  • Ativo Capital Management's GSK position peaked at $1.55M in Q4 2021.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Ativo Capital Management's 13F filing for Q4 2024, filed 3 Feb 2025.